[Event Report] The Second HGPI Dementia Policy Project Roundtable Discussion on “Building an R&D System Together with People Living With Dementia and Their Families – Driving Parallel Progress on an Inclusive Society and in R&D” (November 15, 2022)
date : 11/21/2022
Tags: Dementia
On November 15, 2022, Health and Global Policy Institute (HGPI) held the second roundtable discussion for an initiative titled, “Building an R&D System Together with People Living With Dementia and Their Families – Driving Parallel Progress on an Inclusive Society and in R&D.” The meeting was held online and was not open to the public.
HGPI views dementia and all other aging-related issues as health policy issues at the global level and has made continuous efforts in its capacity as a non-profit, independent health policy think tank to advance policies in this area around the world. In particular, HGPI was early to call for all-of-government initiatives for addressing dementia and has issued multiple recommendations to that end. The fruits of these efforts can be seen in the National Framework for Promotion of Dementia Policies formulated in 2019.
However, addressing lingering issues in this area such as conducting R&D and establishing a dementia-friendly society means we must build an R&D system that allows efforts to be advanced together with people living with dementia and their families. In other fields such as cancer, there have already been initiatives to advance R&D with active involvement from patient advocacy organizations in clinical trials. The field of dementia has also reached the point where we should establish a platform that enables a broad variety of stakeholders to collaborate on the creation of an inclusive society and to promote R&D.
Based on the discussion held at our first roundtable, the discussion at this session focused on promoting participation and collaboration from people living with dementia and their families in various areas and phases of R&D, from healthcare and long-term care to product and service development. We also examined discussion points related to introducing the results of R&D in society and building a foundation for participation and collaboration from people living with dementia and their families.
[Roundtable discussion members] (titles omitted; in Japanese syllabary order; only those who attended are listed)
Takeshi Ikeuchi (Professor, Center for Bioresource-based Researches, Brain Research Institute, Niigata University)
Kenji Ishii (Team Leader, Research Team for Neuroimaging, Tokyo Metropolitan Institute of Gerontology)
Takeshi Iwatsubo (Professor, Department of Basic Neuroscience, Department of Neurology, Graduate School of Medicine, The University of Tokyo; Director, Unit for Early and Exploratory Clinical Development, The University of Tokyo Hospital)
Hidetaka Ota (Professor and Director, Advanced Research Center for Geriatric and Gerontology, Akita University (ARGG))
Hideaki Katagiri (Medical Fellow and Lead Physician, Neuroscience & Pain, Medicine Development Unit Japan and Medical Affairs, Eli Lilly Japan K.K.)
Naomi Sakurai (President, Cancer Solutions Co., Ltd.)
Keisuke Suzuki (Director, Innovation Center for Translational Research, National Center for Geriatrics and Gerontology)
Morio Suzuki (Representative Director, Alzheimer’s Association Japan (AAJ))
Taro Semba (Director, Dementia Project Promotion Office, SOMPO Holdings, Inc.)
Toshihisa Tanaka (Professor, Department of Neuromuscular Pathology, Mie University)
TaisukeTomita (Professor, Laboratory of Neuropathology & Neuroscience, Graduate School of Pharmaceutical Sciences, The University of Tokyo)
Akiko Nakahama (Chief Portfolio Officer, Quality Lead, Alzheimer’s Disease Filing and Registration Japan / Asia, Eisai Co., Ltd.)
Jin Higashijima (Associate Professor, Graduate School of Global and Transdisciplinary Studies, Chiba University)
Masaaki Hirai (Representative, Mahoroba Club)
■Related contents
日本語
Top Research & Recommendations Posts
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Research Paper] “Rethinking Japan’s Health System Sustainability Under the Planetary Health Framework” Published in Health Systems & Reform (November 21, 2023)
- [Research Report] The Public Opinion Survey on Child-Rearing in Modern Japan (Final Report) (March 4, 2022)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Announcement] HGPI Joins Call for “Global Health and Medical Community Unite To Demand End Fossil Fuel Dependency at COP28” (November 1, 2023)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Announcement] HGPI Planetary Health Policy Team Joins Call for Global Fossil Fuel Non-proliferation Treaty (October 18, 2022)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
Featured Posts
-
2024-03-04
[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update: “Issues Surrounding and Necessary Measures Against Obesity Disease” (February 2, 2024)
-
2024-03-05
[HGPI Policy Column] (No.41) – From the Mental Health Project Team – Mental Health Policy in Japan – History and Future Policy Topics (Part 1 of HGPI Activities for Mental Health and Domestic Policy History)
-
2024-03-18
[Registration Open] International Symposium “Promotion of Menopausal Women’s Health as a Social Issue to be Considered by Industry, Government, Academia and the Private Sector” (April 9, 2024)
-
2024-03-22
[Registration Open] (Hybrid Format) The Project for Considering the Future of Precision Medicine with Industry, Government, Academia, and Civil Society – The Global Expert Meeting: Toward Equitable Patient Access to Genomic Cancer Medicine (April 4, 2024)
-
2024-03-26
[Policy Recommendations] Dementia Prevention Initiatives for Achieving a Dementia-Friendly and Inclusive Society (March 26, 2024)